A significant advance in cancer investigation is emerging with the use of nanobodies to reactivate mutated p53. This vital malignant suppressor protein is frequently disabled in many types of malignancies, resulting https://bookmark-nation.com/story21762245/mini-antibodies-reactivate-tumor-suppressor-p53-a-potential-approach-for-cancer-management